Epidemiology of Twinning in the National Birth Defects Prevention Study, 1997 to 2007

被引:9
|
作者
Dawson, April L. [1 ,2 ]
Tinker, Sarah C. [1 ]
Jamieson, Denise J. [3 ]
Hobbs, Charlotte A. [4 ]
Rasmussen, Sonja A. [5 ]
Reefhuis, Jennita [1 ]
机构
[1] Ctr Dis Control & Prevent CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA
[2] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA
[3] CDC, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA
[4] Univ Arkansas Med Sci, Coll Med, Little Rock, AR 72205 USA
[5] CDC, Off Infect Dis, Atlanta, GA 30333 USA
关键词
twinning; ART; IVF; orofacial clefts; clomiphene citrate; IN-VITRO FERTILIZATION; BODY-MASS INDEX; MULTIPLE BIRTHS; PERINATAL OUTCOMES; UNITED-STATES; FOLIC-ACID; RISK; TWINS; SUPPLEMENTATION; PREGNANCIES;
D O I
10.1002/bdra.23325
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
BackgroundOur objective was to evaluate associations between twinning and maternal demographic factors and periconceptional exposures among infants with and without orofacial clefts. MethodsWe used data from the National Birth Defects Prevention Study; 228 twins and 8242 singletons without birth defects (controls), and 117 twins and 2859 singletons with orofacial clefts, born 1997 to 2007, were included in the analyses. Because of the occurrence of twinning due to the use of assisted reproductive technologies, logistic regression models were computed to estimate odds ratios and 95% confidence intervals for each exposure, stratified by fertility treatment use. To evaluate factors by zygosity, we used sex-pairing data and a simulation approach to estimate the zygosity of like-sex twin pairs for unassisted conceptions. ResultsAmong control mothers who did not use fertility treatments, predictors of twinning included non-Hispanic black maternal race (adjusted odds ratio, 1.6; 95% confidence interval, 1.0-2.4), and tobacco smoking (adjusted odds ratio, 1.6; 95% confidence interval, 1.1-2.4). Among control mothers who used fertility treatments, older maternal age, higher income, and state of residence were associated with twinning. Associations were generally stronger among mothers of dizygotic (estimated) twins than monozygotic (estimated) twins. Results for mothers of infants with isolated orofacial clefts were similar to those of controls. ConclusionWe observed an increased twinning frequency with increasing maternal age, but factors such as maternal race/ethnicity and socioeconomic status may also contribute. Among women receiving fertility treatments, factors associated with twinning suggested a relation with treatment specifics (e.g., treatment type and number of embryos implanted) and availability of insurance coverage. Birth Defects Research (Part A) 103:85-99, 2015 (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:85 / 99
页数:15
相关论文
共 50 条
  • [1] Twinning and major birth defects, National Birth Defects Prevention Study, 1997-2007
    Dawson, April L.
    Tinker, Sarah C.
    Jamieson, Denise J.
    Hobbs, Charlotte A.
    Berry, R. J.
    Rasmussen, Sonja A.
    Anderka, Marlene
    Keppler-Noreuil, Kim M.
    Lin, Angela E.
    Reefhuis, Jennita
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2016, 70 (11) : 1114 - 1121
  • [2] Maternal Exposure to Venlafaxine and Risk for Birth Defects, National Birth Defects Prevention Study, 1997-2007
    Duwe, Kara
    Rasmussen, Sonja
    Louik, Carol
    Colarusso, Tiffany
    Reefhuis, Jennita
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S264 - S265
  • [3] Laterality Defects in the National Birth Defects Prevention Study (1998-2007): Birth Prevalence and Descriptive Epidemiology
    Lin, Angela E.
    Krikov, Sergey
    Riehle-Colarusso, Tiffany
    Frias, Jaime L.
    Belmont, John
    Anderka, Marlene
    Geva, Tal
    Getz, Kelly D.
    Botto, Lorenzo D.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2014, 164 (10) : 2581 - 2591
  • [4] ASSOCIATION BETWEEN PREVIOUS FETAL LOSS AND BIRTH DEFECTS, NATIONAL BIRTH DEFECTS PREVENTION STUDY (NBDPS), 1997-2007.
    Polen, K. N. D.
    Alverson, C. J.
    Callaghan, W.
    Canfield, M.
    Correa, A.
    Duke, C. W.
    Marshall, E.
    Olney, R.
    Reefhuis, J.
    Romitti, P.
    Gilboa, S. M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S58 - S58
  • [5] Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007
    Polen, Kara N. D.
    Rasmussen, Sonja A.
    Riehle-Colarusso, Tiffany
    Reefhuis, Jennita
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2013, 97 (01) : 28 - 35
  • [6] EPIDEMIOLOGY OF CHOANAL ATRESIA: THE NATIONAL BIRTH DEFECTS PREVENTION STUDY
    Kancherla, V.
    Romitti, P. A.
    Burns, T. L.
    Carey, J. C.
    Siega-Riz, A. M.
    Druschel, C. M.
    Lin, A.
    Sun, L.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S134 - S134
  • [7] Clomiphene Citrate and Birth Defects, National Birth Defects Prevention Study 1997-2005
    Reefhuis, Jennita
    Honein, Margaret A.
    Schieve, Laura A.
    Rasmussen, Sonja A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S240 - S241
  • [8] The Association between Sertraline, Fluoxetine, and Paroxetine and Major Birth Defects, Data from the National Birth Defects Prevention Study, 1997-2007
    Reefhuis, Jennita
    Friedman, Jan M.
    Louik, Carol
    Colarusso, Tiffany J.
    Devine, Owen J.
    Honein, Margaret A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 376 - 376
  • [9] Descriptive Epidemiology of Maternal Injuries during Pregnancy, National Birth Defects Prevention Study, 1997-2004
    Tinker, S. C.
    Reefhuis, J.
    Dellinger, A. M.
    Jamieson, D. J.
    Honein, M. A.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2009, 85 (05) : 419 - 419
  • [10] Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997-2005
    Reefhuis, J.
    Honein, M. A.
    Schieve, L. A.
    Rasmussen, S. A.
    HUMAN REPRODUCTION, 2011, 26 (02) : 451 - 457